Infantile Pompe Disease: General Information
Topic: Pediatric Health Concerns
Ian C. Langtree - Content Writer/Editor for Disabled World
Published: 2009/04/05 - Updated: 2023/02/01
Contents: Summary - Introduction - Main Item - Related Topics
Synopsis: Pompe disease is a rare, inherited, often fatal disorder that disables the heart and muscles caused by mutations in a gene that makes an enzyme called alpha-glucosidase. Infantile form occurs within the first months of life, with feeding problems, poor weight gain, muscle weakness, floppiness, and head lag. A diagnosis of Pompe disease can be confirmed by screening for common genetic mutations or measuring the level of GAA enzyme activity in a blood sample. This test has 100 percent accuracy.
Introduction
Pompe Disease alternate names: Acid Maltase Deficiency (AMD), Alpha-1,4 Glucosidase Deficiency, Cardiomegalia Glycogenica Diffusa, Generalized Glycogenosis (Cardiac), Glycogen Storage Disease type II, Glycogenosis type II, Lysosomal Glucosidase Deficiency.
Pompe disease is a rare (estimated at 1 in every 40,000 births) inherited and often fatal disorder that disables the heart and muscles. Mutations cause it in a gene that makes an enzyme called alpha-glucosidase (GAA).
The U.S. Social Security Administration (SSA) has included Pompe Disease - Infantile as a Compassionate Allowance to expedite a disability claim.
Main Item
Normally, the body uses GAA to break down glycogen, a stored form of sugar used for energy. But in Pompe disease, mutations in the GAA gene reduce or eliminate this essential enzyme. Excessive amounts of glycogen accumulate everywhere in the body, but the heart and skeletal muscle cells are the most seriously affected.
Researchers have identified up to 70 different mutations in the GAA gene that cause the symptoms of Pompe disease, which can vary widely in terms of age of onset and severity. The severity of the disease and the age of onset are related to the degree of enzyme deficiency.
Infantile form occurs within the first months of life, with feeding problems, poor weight gain, muscle weakness, floppiness, and head lag.
Respiratory difficulties are often complicated by lung infections. The heart is grossly enlarged. More than half of all infants with Pompe disease also have enlarged tongues.
A diagnosis of Pompe disease can be confirmed by screening for common genetic mutations or measuring the level of GAA enzyme activity in a blood sample. This test has 100 percent accuracy.
There is no cure for Pompe disease.
Treatment, therefore, serves only to help minimize the symptoms.
The clinical course is typically not affected by drugs used to treat respiratory or cardiac defects.
A high protein diet may be helpful and has significantly improved respiratory function in some cases.
An enzyme replacement therapy has been developed that has shown, in clinical trials with Infantile Pompe Disease, to decrease heart size, maintain normal heart function, improve muscle function, tone, and strength, and reduce glycogen accumulation.
A drug, alglucosidase alfa (Myozyme), has received FDA approval to treat Pompe disease.
Most babies with the Infantile form of Pompe disease die from cardiac or respiratory complications before their first birthday.
Without enzyme replacement therapy, babies' hearts progressively thicken and enlarge.
Explore Related Topics
1 - How to Make a Baby Stop Crying Using Transport Response - Comparing the effects of the transport response, the relaxed reaction while being carried, with motionless maternal holding or rocking and examining if the effects persist with longer carrying in infants.
2 - Coaxing Kids Through Vaccinations: Pain Expectation is Pain Reality for Children - University of California Riverside researchers examine how expectation of pain influences pain experience in children.
3 - Types of Genetic Mutations Associated with Nephrotic Syndrome Identified - By analyzing most common genetic variants scientists aim at improving diagnosis and treatment for nephrotic syndrome which presents high resistance to drugs and relapse in post-transplant scenario.
4 - Siblings of Cot Death Victims Have Four Times SIDS Risk - Researchers calculated incidence of SIDS in younger siblings compared to the general population and found younger siblings of SIDS victims had four-fold increased risk of SIDS compared to the general population.
5 - Jaundice in the Newborn Baby - Jaundice is actually a symptom not a disease, it is recognized primarily by the yellow discoloration of the skin.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): Langtree, I. C. (2009, April 5 - Last revised: 2023, February 1). Infantile Pompe Disease: General Information. Disabled World. Retrieved October 9, 2024 from www.disabled-world.com/health/pediatric/pompe-disease.php
Permalink: <a href="https://www.disabled-world.com/health/pediatric/pompe-disease.php">Infantile Pompe Disease: General Information</a>: Pompe disease is a rare, inherited, often fatal disorder that disables the heart and muscles caused by mutations in a gene that makes an enzyme called alpha-glucosidase.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.